Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Endeavor Biomedicines, Inc.
National Institutes of Health Clinical Center (CC)
University Hospital, Lille
Dana-Farber Cancer Institute
Fundación GECP
H. Lee Moffitt Cancer Center and Research Institute
Brigham and Women's Hospital
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Memorial Sloan Kettering Cancer Center
University of Pittsburgh
Azienda USL Reggio Emilia - IRCCS
Instituto do Cancer do Estado de São Paulo
University Hospital Southampton NHS Foundation Trust
University of Chicago
Gruppo Oncologico Italiano di Ricerca Clinica
Ain Shams University
Oslo University Hospital
Verastem, Inc.
University of Chicago
University of Florida
Bayer
PrECOG, LLC.
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Baylor College of Medicine
National Institutes of Health Clinical Center (CC)
Wales Cancer Trials Unit
Swiss Cancer Institute
Epizyme, Inc.
National Institutes of Health Clinical Center (CC)
Intergroupe Francophone de Cancerologie Thoracique
Bayer
University of Texas Southwestern Medical Center
Mario Negri Institute for Pharmacological Research
National Institutes of Health Clinical Center (CC)
Columbia University
Novartis
Stanford University
University of Alabama at Birmingham
University Health Network, Toronto
Novartis
Sanofi
AHS Cancer Control Alberta
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
European Lung Cancer Working Party
Wales Cancer Trials Unit
Dana-Farber Cancer Institute